About E. (Elise) van Mulligen, MSc
Introduction
From 2017 onwards I work as PhD student at the department of Rheumatology. The subject of my project is tapering medication in rheumatoid arthritis patients. From 2019 onwards I combine this with coordinating the clinically suspect arthralgia (CSA) cohort, which focuses on early detection of rheumatoid arthritis with the ultimate aim to predict progression towards inflammatory arthritis.
Field(s) of expertise
Rheumatoid Arthritis, clinically suspect arthralgia, tapering medication, cost-effectiveness analysis, patient reported outcomes.
Education and career
I completed a master in biomedical sciences and I am currently specializing as a clinical epidemiologist.
Publications
1. Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study, https://ard.bmj.com/content/78/6/746.long
2. Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al, https://ard.bmj.com/content/early/2019/06/08/annrheumdis-2019-215641.long
3. The impact of a disease flare during tapering of DMARDs on the lives of rheumatoid arthritis patients, https://www.sciencedirect.com/science/article/pii/S0049017220300640?via%3Dihub
Teaching activities
Coaching of medical students.
